UL Solutions Inc. has disclosed recent stock transactions involving its President and CEO, Jennifer F. Scanlon. The transactions, reported in a recent filing, are significant as they reflect the executive's active engagement in the company's stock and can impact investor perception.

Company Overview

UL Solutions Inc. operates in the services-testing laboratories sector, classified under SIC code 8734. The company is traded on the New York Stock Exchange under the ticker symbol ULS. UL Solutions is recognized for its commitment to safety and quality across various industries.

What the Filing Says

In the filing dated November 4, 2026, Scanlon reported the sale of 9,800 shares on November 2, 2026, at an average price of $74.813 per share. Additionally, she sold 2,700 shares at an average price of $75.8282. Following these transactions, Scanlon retains ownership of 116,924 shares directly and 89,285 shares indirectly through a family trust.

Impact

These transactions may affect investor confidence and market perception of UL Solutions. As the President and CEO, Scanlon's decisions regarding stock sales are closely monitored by shareholders and analysts alike. Transparency in executive stock transactions is crucial for maintaining trust with investors.

What's Next

The filing does not say what happens next.

Additional Details from the Filing

The filing reveals that Jennifer F. Scanlon's stock sales were executed under a Rule 10b5-1 trading plan, which was adopted on December 9, 2025. This type of plan allows executives to set up a predetermined schedule for buying or selling stocks, providing a defense against accusations of insider trading.

Furthermore, the transactions involved multiple trades at varying prices. For the sale of 9,800 shares, the prices ranged from $74.36 to $75.35, while the sale of 2,700 shares had a price range from $75.41 to $76.35. The reported prices reflect the weighted average sale prices, and Scanlon has committed to providing detailed information regarding the number of shares sold at each specific price upon request.

In total, following these transactions, Scanlon retains 116,924 shares directly and 89,285 shares indirectly through a family trust, which is managed by her spouse as the trustee, with their children as beneficiaries.

What the Filing Does Not Include

The filing does not provide insights into the reasons behind Scanlon's decision to sell these shares or any potential plans for future transactions. It also does not disclose any information regarding the company's current financial performance or strategic initiatives that may influence stockholder sentiment.